These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 33978462

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
    Dziedzic DA, Rudzinski P, Langfort R, Orlowski T, Polish Lung Cancer Study Group (PLCSG).
    Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lymphatic invasion is a more significant prognostic factor than visceral pleural invasion in non-small cell lung cancer with tumours of 3 cm or less.
    Moon Y, Park JK, Lee KY, Sung SW.
    Respirology; 2017 Aug; 22(6):1179-1184. PubMed ID: 28382791
    [Abstract] [Full Text] [Related]

  • 29. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    Tsutani Y, Mimura T, Kai Y, Ito M, Misumi K, Miyata Y, Okada M.
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
    [Abstract] [Full Text] [Related]

  • 30. Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer.
    Wang C, Wu Y, Shao J, Liu D, Li W.
    BMC Cancer; 2020 Feb 24; 20(1):150. PubMed ID: 32093621
    [Abstract] [Full Text] [Related]

  • 31. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
    Ito T, Murakawa T, Sato H, Tanabe A, Maekawa M, Yoshida Y, Fukayama M, Nakajima J.
    Interact Cardiovasc Thorac Surg; 2012 Oct 24; 15(4):633-8. PubMed ID: 22740516
    [Abstract] [Full Text] [Related]

  • 32. Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging.
    Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.
    Ann Thorac Surg; 2014 May 24; 97(5):1701-7. PubMed ID: 24679941
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T, Koike T, Yamato Y, Yoshiya K, Toyabe S.
    Ann Thorac Surg; 2012 Jun 24; 93(6):1788-94. PubMed ID: 22560265
    [Abstract] [Full Text] [Related]

  • 35. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    Gu C, Wang R, Pan X, Huang Q, Zhang Y, Yang J, Shi J.
    J Cancer Res Clin Oncol; 2017 Nov 24; 143(11):2375-2382. PubMed ID: 28819775
    [Abstract] [Full Text] [Related]

  • 36. Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma.
    Phillips WW, Gill RR, Mazzola E, Armitage JR, de Forcrand C, Colson YL, Gibney BC.
    Ann Thorac Surg; 2021 Oct 24; 112(4):1067-1075. PubMed ID: 33181131
    [Abstract] [Full Text] [Related]

  • 37. Sublobar resection in non-small cell lung cancer: patient selection criteria and risk factors for recurrence.
    Park S, Lee SM, Choe J, Choi S, Kim S, Do KH, Seo JB.
    Br J Radiol; 2023 Oct 24; 96(1150):20230143. PubMed ID: 37561432
    [Abstract] [Full Text] [Related]

  • 38. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
    Speicher PJ, Gu L, Gulack BC, Wang X, D'Amico TA, Hartwig MG, Berry MF.
    Clin Lung Cancer; 2016 Jan 24; 17(1):47-55. PubMed ID: 26602547
    [Abstract] [Full Text] [Related]

  • 39. Lymphovascular Invasion Increases the Risk of Nodal and Distant Recurrence in Node-Negative Stage I-IIA Non-Small-Cell Lung Cancer.
    Sung SY, Kwak YK, Lee SW, Jo IY, Park JK, Kim KS, Lee KY, Kim YS.
    Oncology; 2018 Jan 24; 95(3):156-162. PubMed ID: 29847825
    [Abstract] [Full Text] [Related]

  • 40. Better survival with lobectomy versus sublobar resection in patients with hypermetabolic c-stage IA lung cancer on positron emission tomography/computed tomography.
    Shiono S, Endo M, Watanabe H, Takamori S, Suzuki J.
    Eur J Cardiothorac Surg; 2024 Oct 01; 66(4):. PubMed ID: 39321263
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.